ANDA 62142, held by Watson Labs. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62142 (Doxycycline Hyclate), held by Watson Labs, was first approved by FDA on Aug 12, 1981, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 12, 1981 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 50MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
| Doxycycline HyclateEQ 100MG BASE · capsule;oral | Doxycycline Hyclate | Discontinued |
| Jul 17, 1998 | Supplement 25Manufacturing | Approved | None posted |
| May 23, 1997 | Supplement 24Manufacturing | Approved | None posted |
| Jan 31, 1997 | Supplement 23Manufacturing | Approved | None posted |
| Jan 11, 1994 | Supplement 22Labeling | Approved | None posted |
| Jul 14, 1993 | Supplement 21Labeling | Approved | None posted |
| Aug 24, 1992 | Supplement 19Labeling | Approved | None posted |
| Aug 24, 1992 | Supplement 20Labeling | Approved | None posted |
| May 13, 1992 | Supplement 18Labeling | Approved | None posted |
| Jun 22, 1988 | Supplement 17Manufacturing | Approved | None posted |
| Aug 12, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters